JP Morgan Chase
SER icon

JP Morgan Chase’s Serina Therapeutics SER Stock Holding History

JP Morgan Chase’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$2 ﹤0.01% 7691
2025
Q4 		– Sell
-10
Closed -$54 – 7848
2025
Q3 		$54 Buy
10
+1
+11% +$5 ﹤0.01% 7217
2025
Q2 		$55 Sell
9
-3
-25% -$17 ﹤0.01% 6891
2025
Q1 		$68 Sell
12
-1
-8% -$5 ﹤0.01% 6928
2024
Q4 		$65 Hold
13
– – ﹤0.01% 7078
2024
Q3 		$87 Buy
13
+2
+18% +$16 ﹤0.01% 7022
2024
Q2 		$105 Buy
11
+10
+1,000% +$98 ﹤0.01% 6884
2024
Q1 		$13 Sell
1
-57
-98% -$797 ﹤0.01% 7214
2023
Q4 		$790 Hold
58
– – ﹤0.01% 6867
2023
Q3 		$1.39K Buy
58
+1
+2% +$26 ﹤0.01% 6601
2023
Q2 		$1.8K Buy
+57
New +$1.22K ﹤0.01% 6357
2023
Q1 		– Hold
0
– – – 7304
2022
Q4 		– Hold
0
– – – 7069
2022
Q3 		– Hold
0
– – – 6919
2022
Q2 		– Hold
0
– – – 6952
2022
Q1 		– Hold
0
– – – 7090
2021
Q4 		– Hold
0
– – – 7016
2021
Q3 		– Hold
0
– – – 6868
2021
Q2 		– Hold
0
– – – 6659
2021
Q1 		– Hold
0
– – – 6417
2020
Q4 		– Hold
0
– – – 5981
2020
Q3 		– Sell
-10
Closed -$357 – 5834
2020
Q2 		$0 Sell
10
-981
-99% -$28.9K ﹤0.01% 5750
2020
Q1 		$32K Buy
991
+196
+25% +$9.22K ﹤0.01% 4849
2019
Q4 		$51K Buy
795
+597
+302% +$32.2K ﹤0.01% 5123
2019
Q3 		$14K Buy
198
+32
+19% +$3.04K ﹤0.01% 5463
2019
Q2 		$21K Sell
166
-16
-9% -$2.17K ﹤0.01% 5432
2019
Q1 		$26K Buy
182
+108
+146% +$15.8K ﹤0.01% 5342
2018
Q4 		$8K Buy
+74
New +$9.41K ﹤0.01% 5478

Other funds holding SER

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.69B AUM 20.79% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase's SER Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Serina Therapeutics (SER) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #7691 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in SER as recently as Q3 2025.

JP Morgan Chase first reported a position in SER in Q4 2018 and has held it in 18 quarters since. The position peaked at $51K in Q4 2019. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

  • JP Morgan Chase held 1 share of Serina Therapeutics worth $2 as of Q2 2026.
  • Serina Therapeutics was a new JP Morgan Chase position in Q2 2026.
  • Serina Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7691 holding.
  • JP Morgan Chase first reported a position in Serina Therapeutics in Q4 2018 and has held it in 18 quarters since.
  • JP Morgan Chase's Serina Therapeutics position peaked at $51K in Q4 2019.
  • 27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.